SANDOZ 618 (Rivastigmine 1.5 mg)

This pill with imprint "SANDOZ 618" is Yellow, Capsule-shape and has been identified as Rivastigmine tartrate 1.5 mg. It is manufactured by Sandoz Pharmaceuticals Inc..

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease; lewy body dementia and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rivastigmine tartrate

Imprint:

SANDOZ 618

Strength:

1.5 mg

Color:

Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Cholinesterase inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Sandoz Pharmaceuticals Inc.

National Drug Code (NDC):

00781-2614

Inactive Ingredients:

gelatin
hypromellose
magnesium stearate
microcrystalline cellulose
ferric oxide red
silicon dioxide
titanium dioxide
ferric oxide yellow

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.